BriaCell Therapeutics: Rises on $27.2 mln private placement

Briacell Therapeutics

03/06/2021 17:21

** Shares of drug developer BriaCell Therapeutics Corp
 BCTX.O  up 2.5% at $6.34
    ** Co enters into securities purchase agreements with
accredited investors, to raise gross proceeds of $27.2 mln
 urn:newsml:reuters.com:*:nGNX91fcrN
    ** Co will issue ~5.17 mln units, each unit consisting of
one share of common stock and one warrant to purchase one share
of common stock
    ** Private placement is expected to close on June 7
    ** Co on Wednesday reported average overall survival of 12
months in breast cancer patients treated with its lead candidate
Bria-IMT  urn:newsml:reuters.com:*:nL3N2NK3I9
    ** BCTX had risen ~53% YTD, including session's moves

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))